Magenta Therapeutics Inc (DNTH) Live Share Price, Invest From India

Magenta Therapeutics Inc Stock Performance

as on November 4, 2025 at 2:29 am IST

Day's Low
Day's High
$32.28
Day's Price Range
$35.4
$34.03
5.14%
Downside
4.03%
Upside
52 Week's Low
52 Week's High
$13.37
52-Week Price Range
$40.16
$34.03
60.73%
Downside
18.01%
Upside

Magenta Therapeutics Inc share price movements today

Previous Close: $34.98
Open: $34.52
Volume: 517.7K
Day's Low - High: $32.28 - $35.4
52 Week Low - High: $13.37 - $40.16

Magenta Therapeutics Inc Historical Returns

1 Month Return: -2.6 %
3 Month Return: + 58.28 %
1 Year Return: + 20.33 %
3 Year Return: 0 %
5 Year Return: 0 %

Magenta Therapeutics Inc Stock Fundamentals & Key Indicators

Check Magenta Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-3.4967

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-129.8M

Revenue (TTM)

4.9M

Profit Margin

0.00%

Return On Equity TTM

-34.71%

Magenta Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Magenta Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Magenta Therapeutics Inc	BUY	$1.4B	NA	NA	0.00%
Insmed Incorporated	BUY	$39.7B	455.58%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.2B	211.18%	1425.12	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$109.1B	98.06%	30.31	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$68.5B	9.39%	15.62	32.13%

Stock Returns calculator for Magenta Therapeutics Inc Stock including INR - Dollar returns

The Magenta Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Magenta Therapeutics Inc investment value today

Current value as on today

₹1,26,034

Returns

₹26,034

(+26.03%)

Returns from Magenta Therapeutics Inc Stock

₹20,332 (+20.33%)

Dollar Returns*

₹5,701 (+5.7%)

Analyst Recommendation on Magenta Therapeutics Inc Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Magenta Therapeutics Inc. Average target price of $62.13

Magenta Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Magenta Therapeutics Inc.

What analysts predicted

45.23%UPSIDE

Target Price

$62.13

Current Price

$34.03

Analyzed by

12 Analysts

Target

$62.13

Magenta Therapeutics Inc target price $62.13, a slight upside of 45.23% compared to current price of $34.03. According to 12 analysts rating.

Magenta Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Magenta Therapeutics Inc Stock has decreased by -84% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 5, 2025 to November 4, 2025

Change:-84% versus previous 30 day period

Magenta Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	0	0	0	0	0	1	2	1	1	0
Gross Profit	0	0	0	0	0	1	2	1	1	0
Operating Income	-14	-5	-15	-12	-17	-22	-29	-31	-33	-34
EBITDA	-7	-11	-15	-12	-17	-22	-29	-31	-33	-34
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-29	-3	-14	-10	-13	-17	-25	-28	-29	-31
Income Tax Expense	1	0	-1	0	0	-	-	-	-	-
Net Income	-29	-3	-14	-10	-13	-17	-25	-28	-29	-31
Net Profit Margin	-6128.15%	-338.91%	-1597.73%	-2311.38%	-1573.00%	-945.09%	-1159.02%	-2144.80%	-2537.49%	-16388.08%

Magenta Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	1	6	2	6
Gross Profit	0	6	2	6
Operating Income	-74	-29	-48	-101
EBITDA	-69	-29	-47	-101
Interest Expense	3	-	-	-
Depreciation	-	0	0	0
Income Before Tax	-13	-28	-43	-84
Income Tax Expense	-1	-1	0	-
Net Income	-13	-28	-43	-84
Net Profit Margin	-888.14%	-443.76%	-1541.22%	-1362.77%

Magenta Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-3	-14	-10	-13	-17	-25	-28	-29	-31
Operating Cash Flow	-6	1	-11	-14	-14	-8	-27	-27	-23
Investing Cash Flow	18	-16	-8	-5	1	-259	-23	14	26
Financing Cash Flow	-	154	-4	217	-2	0	39	0	0
Change in Cash	12	94	-24	197	-15	-280	-10	-12	3

Magenta Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-35	-57	-76	-74	-13	-28	-43	-84
Operating Cash Flow	-22	-41	-57	-64	-59	-29	-36	-78
Investing Cash Flow	-2	-91	1	-10	43	-59	20	-286
Financing Cash Flow	71	142	62	67	89	96	133	255
Change in Cash	47	6	6	-6	73	-116	116	-109

Insights on Magenta Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, DNTH stock has moved up by 3.9%
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 178.5% return, outperforming this stock by 154.8%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 941.8% return, outperforming this stock by 859.6%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 7 quarters, -10.56M → -31.62M (in $), with an average decrease of 20.9% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 4 quarters, 2.17M → 193.0K (in $), with an average decrease of 44.9% per quarter

About Magenta Therapeutics Inc

magenta therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based diseases. by creating a platform focused on key areas of transplant medicine, magenta therapeutics is pioneering an integrated, but modular approach to stem cell therapies that reboot the blood and immune systems to create patient benefit. founded by internationally recognized leaders in stem cell transplant medicine, magenta therapeutics was launched in 2016 by third rock ventures and atlas venture and is headquartered in cambridge, mass. for more information, please visit www.magentatx.com.

Organisation	Magenta Therapeutics Inc
Headquarters	7 Times Square, New York, NY, United States, 10036
CEO	Mr. Marino Garcia M.B.A.
E-voting on shares	Click here to vote

Key Management of Magenta Therapeutics Inc

Name	Title
Mr. Marino Garcia M.B.A.	President, CEO & Director
Mr. Simrat Randhawa M.B.A., M.D.	Chief Medical Officer
Mr. Edward G. Carr	Chief Accounting Officer
Ms. Jennifer Davis Ruff	VP and Head of Investor Relations & Corporate Affairs
Mr. Adam M. Veness Esq.	Senior VP, General Counsel & Secretary
Mr. Scott Nogi M.B.A.	Head of Business Operations
Mr. Ryan Savitz	Chief Financial Officer & Chief Business Officer
Mr. Judson Taylor	Senior VP & Head of Technical Operations
Ms. Kristina Maximenko	Chief People Officer
Ms. Rashieda Gluck	Head of Clinical Development Operations

FAQs

What is Magenta Therapeutics Inc share price today?

Magenta Therapeutics Inc share price today is $34.03 as on November 4, 2025 at 2:29 am IST at the close of the market. Magenta Therapeutics Inc share today touched a day high of $35.4 and a low of $32.28.

What is the 52 week high and 52 week low for Magenta Therapeutics Inc share?

Magenta Therapeutics Inc share touched a 52 week high of $40.16 on September 30, 2025 and a 52 week low of $13.37 on April 9, 2025. Magenta Therapeutics Inc stock price today i.e. November 4, 2025 at 2:29 am IST is closed at $34.03,which is 15.26% down from its 52 week high and 154.62% up from its 52 week low.

What is Magenta Therapeutics Inc's market capitalisation today?

Magenta Therapeutics Inc market capitalisation is $0.00T as on November 4, 2025 at 2:29 am IST.

How to invest in Magenta Therapeutics Inc Stock (DNTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Magenta Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Magenta Therapeutics Inc Shares that will get you 0.0441 shares as per Magenta Therapeutics Inc share price of $34.03 per share as on November 4, 2025 at 2:29 am IST.

What is the minimum amount required to buy Magenta Therapeutics Inc Stock (DNTH) from India?

Indian investors can start investing in Magenta Therapeutics Inc (DNTH) shares with as little as ₹88.715 or $1 (as of November 4, 2025 at 11:44 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹887.15 in Magenta Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on November 4, 2025 at 11:44 am IST). Based on Magenta Therapeutics Inc share’s latest price of $34.03 as on November 4, 2025 at 2:29 am IST, you will get 0.2939 shares of Magenta Therapeutics Inc. Learn more about fractional shares .